Patent · US Active

Compositions and methods for evaluation of antiplatelet drug sensitivity

US12235278B2 · kind B2 · utility

0Cited by
1References
17Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 23, 2019
Grant dateFeb 25, 2025
Priority date—
Expiry dateJun 4, 2042

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2800/52
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

In some aspects, the disclosure relates to compositions and methods for detecting phosphorylation of dynamin-related protein 1 (Dip1) at position Ser-616. In some embodiments, methods described by the disclosure are useful for detecting antiplatelet agent sensitivity in a subject. In some embodiments, methods described by the disclosure are useful for detecting if a subject has been previously exposed to an antiplatelet agent.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.